New asthma drug candidate passes early safety check in healthy volunteers
NCT ID NCT05991661
First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This early-stage study tested a new drug called XKH001 in 24 healthy adults to see if it is safe and how the body processes it. Participants received multiple doses of the drug or a placebo. The goal was to check for side effects and measure drug levels in the blood, not to treat asthma. This research helps decide if the drug should be tested in people with asthma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Hospital of Jilin University Phase I Clinical Research Center
Changchun, Jilin, 130000, China
Conditions
Explore the condition pages connected to this study.